Financials

  • Market Capitalization 1.96 B
  • Employee 59
  • Founded 2019
  • CEO N/A
  • Website www.sionnatx.com
  • Headquarter Delaware, United States
  • FIGI BBG016X2DC85
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-21.88
Relación precio/flujo de caja
4 110.11

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1989
ABCL
AbCellera Biologics Inc. - Common Shares
6.63 USD+1.69%-15.97%+21.21%+50.34%2.02 B USD
1990
SRPT
Sarepta Therapeutics, Inc. - Common Stock
18.49 USD-1.75%-2.12%+17.92%-5.28%1.95 B USD
2000
VRDN
Viridian Therapeutics, Inc. - Common Stock
19.10 USD+0.58%-2.05%+15.20%-14.92%1.97 B USD
2008
TYRA
Tyra Biosciences, Inc. - Common Stock
32.00 USD-2.05%+3.66%+17.69%+123.15%1.90 B USD